- Report
- May 2024
- 184 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- May 2024
- 185 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- January 2025
- 284 Pages
Global
From €4608EUR$5,000USD£3,896GBP
- Report
- July 2024
- 130 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- July 2024
- 120 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- April 2025
- 184 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- April 2025
- 187 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- March 2025
- 180 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- February 2025
- 180 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- January 2025
- 185 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- August 2024
- 187 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- July 2024
- 180 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- July 2024
- 182 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- July 2024
- 182 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- June 2024
- 180 Pages
Global
From €4147EUR$4,500USD£3,506GBP
- Report
- May 2025
- 124 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- May 2025
- 114 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- May 2025
- 160 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- May 2025
- 120 Pages
Global
From €4378EUR$4,750USD£3,701GBP
- Report
- August 2024
- 150 Pages
Global
From €3456EUR$3,750USD£2,922GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more